[SCHEDULE 13D/A] BERKSHIRE HATHAWAY SEC Filing

Rhea-AI Filing Summary

On 06/30/2025, Relmada Therapeutics, Inc. (RLMD) filed a Form 4 reporting that officer Chuck Ence received an incentive stock option grant. The award, dated 06/26/2025, covers 400,000 shares of common stock at an exercise price of $0.67 per share. Vesting occurs in 16 equal quarterly installments starting 09/26/2025, with expiration on 06/26/2035. No common shares were purchased or sold; the transaction code was “A” (acquisition from the issuer) and the securities are held directly. After the grant, Ence beneficially owns 400,000 derivative securities. The filing signals continued executive retention efforts and creates potential dilution of up to 400,000 shares if the options are eventually exercised.

Insights

Financial Analyst

TL;DR: 400k options granted to RLMD officer at $0.67; incentive-aligning but only mildly dilutive—overall neutral impact.

The grant represents deferred compensation designed to encourage long-term value creation. A $0.67 strike suggests management confidence relative to the current or anticipated market price, yet no immediate cash outflow occurs for RLMD. If fully exercised, dilution equals 400,000 shares, a modest figure unless the company’s float is very small (not disclosed here). Because this is a standard executive option award without accompanying share sales or purchases, market impact should be minimal and primarily signals retention and incentive alignment rather than a change in insider sentiment.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 79)

Berkshire Hathaway Inc.

(Name of Issuer)

Class A Common Stock, Par Value $5.00 per share

(Title of Class of Securities)

084670108

(CUSIP Number)

Warren E. Buffett
3555 Farnam Street,
Omaha, NE, 68131
402-346-1400

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

06/27/2025

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 084670108

1

Name of reporting person

Warren E. Buffett

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 198,117.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 198,117.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

198,117.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

37.0 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

IN This Schedule 13D amendment relates to the following classes of securities: Class A Common Stock, Par Value $5.00 per share with CUSIP No. 084670108 and Class B Common Stock, Par Value $0.0033 per share with CUSIP No. 084670702. Due to the new Edgar filing requirements, cover pages are limited to one class of security. The cover page of this Schedule 13D filing relates to the Class A Common Stock, and this comment and the notes below shall serve as full disclosure of the beneficial ownership of all classes of securities of the Issuer. Sole Voting Power and Sole Dispositive Power shown in Boxes 7 and 9 consists of 198,117 shares of Class A Common Stock held directly by Mr. Buffett. Mr. Buffett also has sole voting power and sole dispositive power over 1,144 shares of Class B Common Stock held directly by Mr. Buffett. Aggregate amount beneficially owned in Box 9 consists of the Class A Common Stock reported in Boxes 7 and 9. The aggregate amount of Class B Common Stock beneficially owned by Mr. Buffett consists of 1,144 shares of Class B Common Stock, which represents less than 0.01% of the outstanding shares of Class B Common Stock.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Class A Common Stock, Par Value $5.00 per share
(b)	Name of Issuer: Berkshire Hathaway Inc.
(c)	Address of Issuer's Principal Executive Offices: 3555 Farnam Street, Omaha, NEBRASKA , 68131.
Item 1 Comment: EXPLANATORY NOTE Item 5 of this Schedule 13D is amended to add the information set forth below. Except as specifically set forth herein, this Schedule 13D amendment does not modify any of the information previously reported by Mr. Buffett in this Schedule 13D.
Item 5.	Interest in Securities of the Issuer
(a)	Mr. Buffett owns, and has the sole power to vote and to dispose of 198,117 shares of Class A Common Stock and 1,144 shares of Class B Common Stock, representing approximately 37% of the outstanding shares of Class A Common Stock, less than 0.01% of the outstanding shares of Class B Common Stock, 29.7% of the aggregate voting power of the outstanding shares of both classes and 13.8% of the economic interest of the outstanding shares of both classes.
(b)	Information disclosed in Item 5(a).
(c)	On June 27, 2025, Mr. Buffett converted 8,239 shares of Class A Common Stock into 12,358,500 shares of Class B Common Stock. On June 30, 2025, Mr. Buffett donated 9,433,839 shares of Class B Common Stock to the Gates Foundation Trust pursuant to his lifetime commitment. On June 30, 2025, Mr. Buffett donated 943,384 shares of Class B Common Stock to the Susan Thompson Buffett Foundation pursuant to his lifetime commitment. On June 30, 2025, Mr. Buffett donated 660,366 shares of Class B Common Stock to each of the Sherwood Foundation, the Howard G. Buffett Foundation and the NoVo Foundation pursuant to his lifetime commitments.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Warren E. Buffett

Signature:	/s/ Warren E. Buffett
Name/Title:	Warren E. Buffett
Date:	06/30/2025

FAQ

What did Relmada Therapeutics (RLMD) file on 06/30/2025?

RLMD filed a Form 4 disclosing insider equity transactions.

Who is the reporting insider in RLMD's latest Form 4?

The filing lists Chuck Ence, an officer of Relmada Therapeutics.

How many stock options were granted and at what strike price?

Ence received 400,000 options with an exercise price of $0.67 per share.

When do the RLMD options begin vesting and expire?

Vesting starts 09/26/2025 in 16 quarterly tranches, and the options expire on 06/26/2035.

Does the Form 4 indicate any insider sales of RLMD shares?

No. The filing reports an acquisition of derivative securities; no shares were sold.